140 related articles for article (PubMed ID: 10868448)
1. Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis.
Matysiak-Budnik T; de Mascarel A; Abely M; Mayo K; Heyman M; Mégraud F
Scand J Gastroenterol; 2000 May; 35(5):470-5. PubMed ID: 10868448
[TBL] [Abstract][Full Text] [Related]
2. Antral gastric permeability to antigens in mice is altered by infection with Helicobacter felis.
Matysiak-Budnik T; Hashimoto K; Heyman M; de Mascarel A; Desjeux JF; Mégraud F
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1371-7. PubMed ID: 10654797
[TBL] [Abstract][Full Text] [Related]
3. Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide.
Matysiak-Budnik T; Thomas-Collignon A; Mégraud F; Heyman M
Dig Dis Sci; 2001 Jul; 46(7):1558-66. PubMed ID: 11478510
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
5. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
[TBL] [Abstract][Full Text] [Related]
6. Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication.
Nishizawa T; Suzuki H; Nakagawa I; Minegishi Y; Masaoka T; Iwasaki E; Hibi T
Digestion; 2009; 79(4):259-62. PubMed ID: 19420943
[No Abstract] [Full Text] [Related]
7. Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
Fujioka T; Arakawa T; Shimoyama T; Yoshikawa T; Itoh M; Asaka M; Ishii H; Kuwayama H; Sato R; Kawai S; Takemoto T; Kobayashi K
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():146-52. PubMed ID: 12925153
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori increases the epithelial permeability to a food antigen in human gastric biopsies.
Matysiak-Budnik T; Coffin B; Lavergne-Slove A; Sabate JM; Mégraud F; Heyman M
Am J Gastroenterol; 2004 Feb; 99(2):225-32. PubMed ID: 15046209
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori.
Hahm KB; Lee KJ; Kim YS; Kim JH; Cho SW; Yim H; Joo HJ
Dig Dis Sci; 1998 Sep; 43(9 Suppl):192S-197S. PubMed ID: 9753249
[TBL] [Abstract][Full Text] [Related]
10. Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
Hahm KB; Lee KJ; Kim YS; Kim JH; Cho SW; Yim H; Joo HJ
Dig Dis Sci; 1998 Feb; 43(2):235-40. PubMed ID: 9512112
[TBL] [Abstract][Full Text] [Related]
11. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K;
J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133
[TBL] [Abstract][Full Text] [Related]
12. Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
Suzuki H; Mori M; Kai A; Suzuki M; Suematsu M; Miura S; Ishii H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):181S-187S. PubMed ID: 9753247
[TBL] [Abstract][Full Text] [Related]
13. Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.
Matysiak-Budnik T; van Niel G; Mégraud F; Mayo K; Bevilacqua C; Gaboriau-Routhiau V; Moreau MC; Heyman M
Infect Immun; 2003 Sep; 71(9):5219-24. PubMed ID: 12933867
[TBL] [Abstract][Full Text] [Related]
14. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
15. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
[TBL] [Abstract][Full Text] [Related]
16. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T
Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820
[TBL] [Abstract][Full Text] [Related]
17. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
Higuchi K; Arakawa T; Nebiki H; Uchida T; Fujiwara Y; Ando K; Yamasaki K; Takaishi O; Fukuda T; Kobayashi K; Kuroki T
Dig Dis Sci; 1998 Sep; 43(9 Suppl):99S-106S. PubMed ID: 9753234
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells.
Joh T; Takezono Y; Oshima T; Sasaki M; Seno K; Yokoyama Y; Ohara H; Nomura T; Alexander JS; Itoh M
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():133-8. PubMed ID: 12925151
[TBL] [Abstract][Full Text] [Related]
19. Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test.
Iijima K; Ichikawa T; Okada S; Ogawa M; Koike T; Ohara S; Shimosegawa T
Dig Dis Sci; 2009 Jul; 54(7):1500-7. PubMed ID: 18975081
[TBL] [Abstract][Full Text] [Related]
20. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
